Curis (CRIS) Interest Coverage Ratio (2013 - 2025)

Curis (CRIS) reported Interest Coverage Ratio of 62.48 for Q4 2025, up 691.19% on a YoY basis from 7.9 in Q4 2024, and up 898.61% quarter-over-quarter from 7.82 in Q3 2025.

Curis (CRIS) Interest Coverage Ratio (2013 - 2025) Analysis & Trends

Curis has reported Interest Coverage Ratio for 13 years, with the latest figure at 62.48 in Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 691.19% year-over-year to 62.48; the trailing twelve-month figure through Mar 2026 stood at 4.33 (up 87.23% YoY), and the FY2025 full-year result was 2.61, up 96.39% from the prior year.
  • Interest Coverage Ratio for Q4 2025 stood at 62.48, up from 7.82 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 1564.0 in Q2 2024, with the low at 68.53 in Q4 2023.
  • Historically, Interest Coverage Ratio has averaged 79.42 across 5 years, with a median of 10.97 in 2021.
  • Annual changes were most pronounced in 2023 — Interest Coverage Ratio sank 1007.13% — and 2024, when it surged 8320.73%.
  • Curis' Interest Coverage Ratio stood at 11.36 in 2021, then jumped by 45.52% to 6.19 in 2022, then slumped by 1007.13% to 68.53 in 2023, then surged by 84.58% to 10.57 in 2024, then soared by 691.19% to 62.48 in 2025.
  • The last three Interest Coverage Ratio figures came in at 62.48 (Q4 2025), 7.82 (Q3 2025), and 19.01 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 3.58
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -258.33
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 11.50
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 547.67
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -
9 Abivax 95.45 Bn 95.45 Bn - 11.79
10 Curis 8.58 Mn -6.42 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 62.48
Sep 30, 2025 -7.82
Jun 30, 2025 -19.01
Mar 31, 2025 -18.40
Dec 31, 2024 -10.57
Sep 30, 2024 70.45
Jun 30, 2024 1,564.00
Mar 31, 2024 159.86
Dec 31, 2023 -68.53
Sep 30, 2023 -19.98
Jun 30, 2023 -19.03
Mar 31, 2023 -19.91
Dec 31, 2022 -6.19
Sep 30, 2022 -12.32
Jun 30, 2022 -14.47
Mar 31, 2022 -14.33
Dec 31, 2021 -11.36
Sep 30, 2021 -9.51
Jun 30, 2021 -9.38
Mar 31, 2021 -7.50